אולנזאפין דקסל 5 מ"ג

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

OLANZAPINE 5 MG

Доступно од:

DEXCEL PHARMA TECHNOLOGIES LTD

АТЦ код:

N05AH03

Фармацеутски облик:

TABLETS

Пут администрације:

PER OS

Произведен од:

DEXCEL LTD

Терапеутска група:

OLANZAPINE

Терапеутске индикације:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Датум одобрења:

2012-05-01